Safety and Efficacy Assessment of HAV (Manufactured Using Large-scale System) in Patients Needing Vascular Access for Dialysis

Conditions:   Renal Failure;   End Stage Renal Disease;   Vascular Access;   Hemodialysis Intervention:   Biological: HAV Sponsor:   Humacyte, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials